Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: HIKMA PHARMACEUTICALS USA INC.
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-01-24 to 2022-01-27
Current total value of award: $351.84
Description: 4556053309!MORPHINE SULFATE (PF) INTRAVENOUS SOLUTI